SPDR S&P Biotech Company Profile (NYSEARCA:XBI)

About SPDR S&P Biotech (NYSEARCA:XBI)

SPDR S&P Biotech logoSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Exchange Traded Fund
  • Sub-Industry: N/A
  • Symbol: NYSEARCA:XBI
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $69.34
  • 200 Day Moving Avg: $66.53
  • 52 Week Range: $49.51 - $72.58
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Misc:
  • Average Volume: 4.15 million shs.
 

Frequently Asked Questions for SPDR S&P Biotech (NYSEARCA:XBI)

What is SPDR S&P Biotech's stock symbol?

SPDR S&P Biotech trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

How often does SPDR S&P Biotech pay dividends? What is the dividend yield for SPDR S&P Biotech?

SPDR S&P Biotech announced a quarterly dividend on Friday, March 17th. Shareholders of record on Tuesday, March 21st will be paid a dividend of $0.0197 per share on Monday, March 27th. This represents a $0.08 dividend on an annualized basis and a yield of 0.11%. The ex-dividend date of this dividend is Friday, March 17th. This is a positive change from SPDR S&P Biotech's previous quarterly dividend of $0.02. View SPDR S&P Biotech's Dividend History.

Who are some of SPDR S&P Biotech's key competitors?

How do I buy SPDR S&P Biotech stock?

Shares of SPDR S&P Biotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of SPDR S&P Biotech stock cost?

One share of SPDR S&P Biotech stock can currently be purchased for approximately $68.72.

Analyst Ratings

Consensus Ratings for SPDR S&P Biotech (NYSEARCA:XBI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SPDR S&P Biotech (NYSEARCA:XBI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SPDR S&P Biotech (NYSEARCA:XBI)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/17/2017quarterly$0.020.11%3/17/20173/21/20173/27/2017
12/16/2016quarterly$0.020.12%12/16/201612/20/201612/27/2016
6/19/2015quarterly$0.440.69%6/19/20156/23/20156/29/2015
3/20/2015quarterly$0.250.42%3/20/20153/24/20153/30/2015
12/19/2014quarterly$0.491.03%12/19/201412/23/201412/30/2014
9/19/2014quarterly$0.561.42%9/19/20149/23/20149/29/2014
6/20/2014quarterly$0.621.61%6/20/20146/24/20146/30/2014
3/21/2014quarterly$0.330.87%3/21/20143/25/20143/31/2014
12/20/2013quarterly$0.040.12%12/20/201312/24/201312/31/2013
9/20/2013quarterly$0.090.27%9/20/20139/24/20139/30/2013
3/15/2013quarterly$0.040.18%3/15/20133/19/20133/25/2013
12/21/2012quarterly$0.200.89%12/21/201212/26/20121/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for SPDR S&P Biotech (NYSEARCA:XBI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for SPDR S&P Biotech (NYSEARCA:XBI)
Latest Headlines for SPDR S&P Biotech (NYSEARCA:XBI)
Source:
DateHeadline
americanbankingnews.com logoSPDR S&P Biotech Target of Unusually High Options Trading (XBI)
www.americanbankingnews.com - May 24 at 12:52 PM
nasdaq.com logoFriday's ETF Movers: ILF, XBI - Nasdaq
www.nasdaq.com - May 21 at 7:38 PM
americanbankingnews.com logoInvestors Buy Large Volume of Put Options on SPDR S&P Biotech (XBI)
www.americanbankingnews.com - May 21 at 7:04 AM
nasdaq.com logoThe Latest Market Trends Every Biopharma Investor Needs to Know - Nasdaq
www.nasdaq.com - May 17 at 11:10 PM
finance.yahoo.com logoWhy Biotech Stocks Are Hitting the Skids
finance.yahoo.com - May 15 at 8:21 AM
nasdaq.com logoNotable ETF Outflow Detected - XBI, EXAS, VRTX, IONS - Nasdaq
www.nasdaq.com - May 11 at 3:18 PM
nasdaq.com logoMonday's ETF Movers: XOP, XBI
www.nasdaq.com - May 9 at 8:15 PM
barrons.com logoETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain - Barron's
www.barrons.com - May 8 at 8:15 PM
finance.yahoo.com logoETF Flopper: Biotechnology and Pharmaceuticals Feel the Pain
finance.yahoo.com - May 8 at 8:15 PM
americanbankingnews.com logoSPDR S&P Biotech Target of Unusually Large Options Trading (XBI)
www.americanbankingnews.com - May 7 at 7:08 AM
blogs.barrons.com logoA Biotech Warning Sign? - Barron's (blog)
blogs.barrons.com - May 6 at 3:40 PM
investopedia.com logoWhat to Do With These Strong ETFs (SMH, KBE)
www.investopedia.com - May 6 at 2:04 AM
nasdaq.com logoFriday's ETF Movers: FXN, XBI
www.nasdaq.com - May 6 at 2:04 AM
finance.yahoo.com logoETF Flopper: Biotech Bungle
finance.yahoo.com - May 6 at 2:04 AM
finance.yahoo.com logoBiotech ETF Rides Industry's Recovery
finance.yahoo.com - May 6 at 2:04 AM
barrons.com logoA Biotech Warning Sign? - Barron's
www.barrons.com - May 5 at 5:04 AM
nasdaq.com logoNoteworthy ETF Inflows: XBI, VRTX, IONS, SRPT - Nasdaq
www.nasdaq.com - May 3 at 7:03 PM
barrons.com logoFour Small Biotechs See Bullish April Stock Buys - Barron's
www.barrons.com - May 3 at 9:38 AM
finance.yahoo.com logoThis Biotech ETF Has 'Bullish Potential'
finance.yahoo.com - May 2 at 6:49 PM
finance.yahoo.com logoUnderstanding Exelixis’s Operating Expense Expectations for 1Q17
finance.yahoo.com - April 26 at 5:20 PM
americanbankingnews.com logoSPDR S&P Biotech Sees Unusually High Options Volume (XBI)
www.americanbankingnews.com - April 21 at 7:03 AM
nasdaq.com logoWednesday's ETF Movers: XBI, GDXJ - Nasdaq
www.nasdaq.com - April 20 at 1:29 AM
finance.yahoo.com logoWhy biotech stocks are a healthy bet in a sickly broader market
finance.yahoo.com - April 20 at 1:29 AM
forbes.com logoHow To Play It: Carl Icahn
www.forbes.com - April 18 at 7:51 PM
americanbankingnews.com logoStock Traders Buy Large Volume of Put Options on SPDR S&P Biotech (XBI)
www.americanbankingnews.com - April 17 at 5:21 PM
nasdaq.com logoThursday's ETF Movers: XBI, GDXJ - Nasdaq
www.nasdaq.com - April 13 at 3:22 PM
finance.yahoo.com logoThe Larger Aims of Obamacare: An Overview
finance.yahoo.com - April 11 at 10:54 PM
finance.yahoo.com logoHow to trade gridlock in Washington
finance.yahoo.com - April 7 at 6:38 PM
nasdaq.com logoThursday's ETF Movers: XRT, XBI
www.nasdaq.com - April 7 at 6:38 PM
us.rd.yahoo.com logoIs Rising Consumer Sentiment Helping the Market Rally in 2017?
us.rd.yahoo.com - March 30 at 8:34 PM
nasdaq.com logoThursday's ETF Movers: KRE, XBI - Nasdaq
www.nasdaq.com - March 30 at 3:34 PM
marketwatch.com logoTax reform could be a back door for another Republican Obamacare repeal attempt
www.marketwatch.com - March 27 at 8:02 PM
benzinga.com logoFast Money Traders Share Their Trades After Cancelled Healthcare Vote - Benzinga
www.benzinga.com - March 27 at 8:08 AM
marketwatch.com logoWhere Trump can do to undermine Obamacare, now the GOP health bill has failed
www.marketwatch.com - March 25 at 9:30 PM
investopedia.com logoStalling Healthcare Reform May Be Holding Up the Rally
www.investopedia.com - March 24 at 2:36 AM
blogs.barrons.com logoBiotechnology Gets A Shot In the Arm
blogs.barrons.com - March 21 at 3:29 PM
marketwatch.com logoBiotech firm says it’s closing in on the cancer that killed Steve Jobs
us.rd.yahoo.com - March 20 at 6:49 PM
investorplace.com logoHow to Profit From the Bulls’ Return to Biotech Stocks (XBI)
investorplace.com - March 16 at 4:04 PM
blogs.barrons.com logoBiogen Weighs On Biotech ETFs; Time to Bail?
blogs.barrons.com - March 16 at 4:04 PM
finance.yahoo.com logoTime to Buy Biotech ETF?
finance.yahoo.com - March 13 at 8:22 PM
nasdaq.com logoONCE Makes Notable Cross Below Critical Moving Average - Nasdaq
www.nasdaq.com - March 12 at 12:29 AM
thestreet.com logoTrump Expected to Name Scott Gottlieb as FDA Commissioner - TheStreet.com
www.thestreet.com - March 12 at 12:29 AM
marketwatch.com logoTrump administration expected to name VC partner Gottlieb to head FDA
www.marketwatch.com - March 11 at 11:24 AM
thestreet.com logoTrump Expected to Name Scott Gottlieb as FDA Commissioner
www.thestreet.com - March 11 at 11:24 AM
benzinga.com logoBiotech, Ciena, Nike, Panera: Fast Money Picks For March 9 - Benzinga
www.benzinga.com - March 10 at 6:10 AM
blogs.barrons.com logo3 Biotech Stocks to Buy Now…and 1 to Dump ASAP - Barron's (blog)
blogs.barrons.com - March 10 at 6:10 AM
thestreet.com logoThese Health Care ETFs Could Be in Play with the GOP's ACA Repeal
www.thestreet.com - March 10 at 6:10 AM
marketwatch.com logoPharma and biotech stocks slump after President Trump tweets about lowering drug prices
us.rd.yahoo.com - March 8 at 2:04 AM
us.rd.yahoo.com logoAre You In The Best Health Care ETF? GOP Moves To Replace ObamaCare
us.rd.yahoo.com - March 8 at 2:04 AM
us.rd.yahoo.com logoBiotech: When @RealDonaldTrump Shows Up
us.rd.yahoo.com - March 8 at 2:04 AM

Social

Social activity is not available for this stock.
This page was last updated on 5/27/2017 by MarketBeat.com Staff